New Delhi: As the UK begins vaccinating people with Pfizer’s coronavirus vaccine, a huge concern has emerged that has called into question the safety of vaccines. According to regulators from the United States Food and Drug Administration (FDA), four volunteers who received the vaccine injections during the testing phase developed Bell’s palsy. In particular, Bell’s palsy is a medical condition that causes half of the face to sag. Also Read – Coronavirus: Canada’s Health Regulator Approves Pfizer’s COVID-19 Vaccine
The drug regulator has maintained that it was unclear what led to Bell’s palsy in the aforementioned volunteers. Reports say that regulators have asked doctors to constantly monitor the side effects of the vaccine. Also Read – Poet, Writer Manglesh Dabral Dies Of Coronavirus, Political Leaders Express Condolences
Earlier, Pfizer CEO Albert Bourla had cast doubt on whether the vaccine will help stop the transmission of the infection. During an interview with NBC’s Lestor Holt, the company’s CEO was asked if a vaccinated person can still pass the virus on to other people. To which, he had replied, “I think this is something that needs to be looked into. We’re not sure about that at this point with what we know. ” Read Also – Coronavirus: UK Issues Allergy Warning On Pfizer Vaccine After Two Adverse Reactions
A report on the subject also noted that researchers (those not associated with the development of the vaccine) have expressed concern that the company has not evaluated in its trials how the vaccine plays a role in transmitting the disease.
The UK had previously become the first country to approve the Pfizer / BioNTech Covid-19 vaccine, and the UK Medicines and Healthcare Products Regulatory Agency (MHRA) granted a temporary authorization for its emergency use.
Yesterday, Britain’s drug regulator issued a warning that people with a “significant” history of allergic reactions to drugs, foods or vaccines should not receive the Pfizer / BioNTech injection, just one day after the first group of Patients will receive the first of two doses of the COVID-19 vaccine. The warning came after two National Health Service (NHS) workers experienced symptoms of an “anaphylactoid reaction” shortly after being injected, but are now said to be recovering well.
.
